BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 15, 2001
View Archived Issues
Licensing opportunity from NIH: analogues of thalidomide as potential angiogenesis inhibitors
Read More
NIH licensing opportunity: methods and compositions for inhibiting HIV-coreceptor interactions
Read More
Antiinfluenza activity of BioCryst's cyclopentane neuraminidase inhibitor studied
Read More
Introgen's INGN-241 demonstrates potent antitumor properties in preclinical studies
Read More
Avant initiates second phase IIb trial of TP-10 in infants
Read More
Xenova reports Q1 highlights; merger with Cantab completed
Read More
Postprandial TG-lowering effects of NK-104 investigated in animal model
Read More
FM-VP4 highlighted at recent AHA conference as novel therapy for cardiovascular disease
Read More
Active metabolite of leflunomide proven to suppress eotaxin production
Read More
Therapeutic pipeline update provided by BioChem Pharma
Read More
Cannabinoid receptor agonist reduces IOP in monkeys with and without glaucoma
Read More
GSK designs and characterizes a new, high-affinity, selective PPARdelta agonist
Read More
Baxter seeks FDA approval to evaluate Neuprex for Crohn's disease
Read More
FDA clears phase II trials of novel immunosuppressive drug
Read More
Independent DSMB recommends continuation of phase III Theratope trial
Read More
Polypeptide with potential in gene therapy for immunodeficiency discovered at Hayashibara
Read More
Safety of mitoxantrone in MS patients highlighted at AAN meeting
Read More
Durect completes clinical portion of DUROS sufentanil phase II trial
Read More
MCH antagonists and use in obesity disclosed by Takeda
Read More
Potent and selective alpha1-adrenoceptor ligands reported by Lundbeck
Read More
Bivalent FVIIa/TF/FXa complex inhibitors
Read More
Shionogi prepares and tests new CB2 receptor ligands
Read More
Prostaglandin derivatives claimed by Taisho for inducing sleep, Rx of renal and cardiac disorders
Read More
Inhibitors of protein prenyltransferases identified by Dutch researchers
Read More
Company Profile: Conforma Therapeutics
Read More
NicOx nitric oxide-releasing steroid shows no blanching effect in phase I
Read More